Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-05-12 to 2023-02-28
Current total value of award: $80.98
Description: 8509097582!DILTIAZEM HYDROCHLO